NCT00479583 Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX Status COMPLETED Phase PHASE1
NCT00468169 Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00461110 A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) Status TERMINATED Phase PHASE1
NCT00460954 A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects Status COMPLETED Phase N/A
NCT00457002 Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness Status COMPLETED Phase PHASE3
NCT00455533 Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer Status COMPLETED Phase PHASE2
NCT00455013 A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation Status COMPLETED Phase PHASE2
NCT00452673 Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT00452530 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery Status COMPLETED Phase PHASE3
NCT00448097 Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy Status TERMINATED Phase PHASE2
NCT00447070 Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Status COMPLETED Phase PHASE4
NCT00444678 Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00444015 Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1
NCT00442611 A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Status COMPLETED Phase PHASE1/PHASE2
NCT00441337 A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies Status COMPLETED Phase PHASE1